Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 30, 2015 9:04 PM ET

Pharmaceuticals

Company Overview of Edge Therapeutics, Inc.

Key Executives for Edge Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Brian A. Leuthner 32 RelationshipsCo-Founder, Chief Executive Officer, President and Director--
R. Loch MacDonald M.D., Ph.D.32 RelationshipsCo-Founder, Chief Scientific Officer and Director--
Carl J. Soranno Esq.32 RelationshipsCo-Founder, Executive Vice President of Corporate Development and Director--
Andrew J. Einhorn CPANo RelationshipsChief Financial Officer55
Albert Marchio No RelationshipsChief Accounting and Operations Officer--
View More Key Executives

Edge Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sol J. Barer Ph.D. 143 RelationshipsDel Mar Pharmaceuticals Inc.68
Brian A. Leuthner 32 RelationshipsEdge Therapeutics, Inc.--
Isaac Blech 100 RelationshipsCerecor Inc.65
Carl J. Soranno Esq. 32 RelationshipsEdge Therapeutics, Inc.--
R. Loch MacDonald M.D., Ph.D. 32 RelationshipsEdge Therapeutics, Inc.--
View All Board Members

Edge Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee Ph.D.Sol J. Barer143 Relationships1 Executives
Advisory Board Jr., Ph.D., Sc.DRobert S. Langer472 Relationships23 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
456.8K
Bonus
529.2K
Total Short Term Compensation
648.1K
Total Value of Options
22.7M
Compensation as of Fiscal Year
Edge Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

The Procter & Gamble Company Announces Executive Changes
July 28, 2015 9:53 AM ET
Aunt Fannies Appoints Barclay Hope as Board of Advisors
July 13, 2015 1:22 PM ET
Anpath Group, Inc. Elects Arthur R. Batson as Chief Executive Officer and President
July 09, 2015 8:43 PM ET
Katy Industries, Inc. Announces Executive and Management Changes
July 08, 2015 5:13 PM ET
Energizer Holdings, Inc. Announces Management Changes
July 07, 2015 12:31 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Edge Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.